Management des HELLP-Syndroms

Conference paper


Das HELLP-Syndrom stellt eine schwere, lebensbedrohliche Verlaufsform der Präeklampsie mit typischer laborchemischer Konstellation dar.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Heller CS, Elliot JP (1997) High order multiple pregnancies complicated by HELLP Syndrome: a report of four cases with corticosteroid therapy to prolong gestation. J Reprod Med 42:743–746PubMedGoogle Scholar
  2. 2.
    Heilmann L, Rath W, Wacker J (1998) Diagnostik, Therapie und geburtshilfliches Vorgehen bei schweren hypertensiven Schwangerschaftserkrankungen. Frauenarzt 39:1706–1716Google Scholar
  3. 3.
    Magann EF, Perry KG, Meydrech EF, Harris RL, Chauhan SP, Martin JN (1994) Postpartum corticosteroids: accelerated recovery for the Syndrome of HELLP. Am J Obstet Gynecol 171: 1154–1158PubMedGoogle Scholar
  4. 4.
    Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN (1994) Antepartum corticosteroids: diseases stabilization in patients with a Syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 171:1148–1153PubMedGoogle Scholar
  5. 5.
    Magann EF, Perry KG, Chauhan SP, Graves GR, Blake PG, Martin JN (1994) Neonatal salvage by weeks’ gestation in pregnancies complicated by HELLP-syndrome, J Soc Gynecol Invest 1: 206–209Google Scholar
  6. 6.
    Martin JN, Perry KG, Blake PG, May WA, Moore A, Robinette L (1997) Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP Syndrome. Am J Obstet Gynecol 177:1011–1017PubMedCrossRefGoogle Scholar
  7. 7.
    Niesert S (1996) Geburtshilfliche Prognose nach Präeklampsie, Eklampsie und HELLP-Syndrom. Geburtshilfe Frauenheilkd 56:93–96PubMedCrossRefGoogle Scholar
  8. 8.
    Odendaal HJ, Pattinson RC, Baum R, Grove D, Kotze TJW (1990) Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks’ gestation: a randomized controlled trial. Obstet Gynecol 76:1070–1075PubMedGoogle Scholar
  9. 9.
    Olah KS, Redman CWG, Gee H (1993) Management of severe, early preeclampsia: is conservative management justified? Eur J Obstet Gynec Reprod Biol 51:175–180CrossRefGoogle Scholar
  10. 10.
    Rath W (1992) Diagnostische und therapeutische Probleme beim HELLP-Syndrom. Z Geburtsh Perinatol 196:185–192Google Scholar
  11. 11.
    Rath W, Loos W, Kuhn W, Graeff H (1992) Das HELLP-Syndrom. Gynäkologe 25:430–440PubMedGoogle Scholar
  12. 12.
    Rath W (1994) Das HELLP-Syndrom. Zentralbl Gynäkol 116:195–201PubMedGoogle Scholar
  13. 13.
    Rath W (1996) Aggressives versus konservatives Vorgehen beim HELLP-Syndrom: eine Standortbestimmung. Geburtshilfe Frauenheilkd 56:265–271PubMedCrossRefGoogle Scholar
  14. 14.
    Rath W (1998) Das geburtshilfliche Vorgehen beim HELLP-Syndrom - eine aktuelle klinische Kontroverse. Frauenarzt 39:79–80Google Scholar
  15. 15.
    Sibai BM, Mercer BM, Schiff E, Friedman SA (1994) Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial. Am J Obstet Gynecol 171:818–822PubMedGoogle Scholar
  16. 16.
    Sibai BM, Ramadan MK, Usta J, Salama M, Mercer BM, Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP-syndrome). Am J Obstet Gynecol 169:1000–1006PubMedGoogle Scholar
  17. 17.
    Visser W Wallenburg HCS (1995) Temporising management of severe preeclampsia with and without the HELLP Syndrome. Br J Obstet Gynaecol 102:111–117PubMedCrossRefGoogle Scholar
  18. 18.
    Wacker J,Werner P, Walter-Sack J, Bastert G (1998) Treatment of hypertension in patients with preeclampsia: a prospective parallel-group study comparing dihydralazine with Urapidil. Nephrol Dial Transplant 13:318–325.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • W. Rath

There are no affiliations available

Personalised recommendations